CDK4 and CDKN2A cut-off reference for RNA overexpression
tumor
TUMOR
For determining tumoral RNA overexpression of Additionally, the performance of a pre-screening of RNA expression for both genes in archival tumor samples was allowed, under the presumption that if in line with the inclusion criteria, there would be a higher probability of complying with the RNA expression values for the accrual in the baseline biopsy.